The Brincidofovir Tablets, cataloged under National Stock Number 6505-01-696-1752, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-696-1752 |
| Primary Part Number | NDC79622-0010-04 |
| Item Name | Brincidofovir Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC79622-0010-04 PRIMARY | Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM217204 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1597843 | 5/1 Secondary reference U.S. Government activity |
| NDC79622-0010-04 | 3/9 Design control — primary reference Chimerix, Inc. |
NSN 6505-01-696-1752 is a Brincidofovir Tablets, manufactured by Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-696-1752 has 1 manufacturer part number on file: NDC79622-0010-04 (Emergent Biodefense Operations Lansing Llc Dba Emergent Biodefense).
Key specifications for NDC79622-0010-04: Special Features: INDICATED FOR THE TREATMENT OF HUMAN SMALLPOX DISEASE CAUSED BY VARIOLA VIRUS IN ADULT AND PEDIATRIC PATIENTS, INCLUDING NEONATES; TABLETS ARE BLUE, MODIFIED-OVAL SHAPE, FILM-COATED TABLETS DEBOSSED WITH BCV ON ONE SIDE AND 100 ON THE OTHER SIDE AND PACKAGED INTO BLISTER CARDS; CONTAINS ONE (1) BLISTER CARD WITH A TOTAL OF 4 FILM-COATED TABLETS; STORE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED FROM 15 C TO 30 C (59 F TO 86 F. (SEE USP CONTROLLED ROOM TEMPERATURE); FOR ORAL USE; DO NOT DIVIDE, BREAK, OR CRUSH THE TABLETS; SHELF LIFE: 24 MONTHS.; Part Name Assigned by Controlling Agency: BRINCIDOFOVIR TABLETS, 4S, 100MG. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.